Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Xeris Biopharma Holdings Inc. buy Jefferies Financial Group Inc.

Xeris Biopharma Holdings Inc.
Start price
€3.49
03.02.25 / 50%
Target price
€5.81
03.02.26
Performance (%)
75.07%
End price
€6.11
04.02.26
Summary
This prediction ended on 04.02.26 with a price of €6.11. The BUY prediction by Jefferies_Financial_ for Xeris Biopharma Holdings Inc. saw massive gains of 75.07%. Jefferies_Financial_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Xeris Biopharma Holdings Inc. 3.416% 3.416% 16.629%
iShares Core DAX® 0,88 % 5,63 % 8,48 %
iShares Nasdaq 100 2,39 % 1,57 % 28,41 %
iShares Nikkei 225® 4,27 % 2,52 % 50,98 %
iShares S&P 500 1,17 % 2,55 % 23,60 %

Comments by Jefferies_Financial_ for this prediction

In the thread Xeris Biopharma Holdings Inc. diskutieren
Prediction Buy
Perf. (%) 75.07%
Target price 5.810
Change
Ends at 03.02.26

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $6.00 price target on the stock, up previously from $4.00.
Ratings data for XERS provided by MarketBeat

Jefferies Financial Group Inc. 
0
Report Share
03.02.25
In the thread Trading Xeris Biopharma Holdings Inc.
Prediction Buy
Perf. (%) 75.07%
Target price 5.810
Change
Ends at 03.02.26

Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten

Jefferies Financial Group Inc. 
0
Report Share
04.02.26